Fake weight-loss tablets could become the next lucrative sideline for Britain’s online medicine fraudsters after the MHRA approved an oral semaglutide treatment for weight management on 11 June 2026.
The needle-free option may appeal to patients uncomfortable with injections, but Sobia Qasim, Superintendent Pharmacist at Curely, warns that its familiar format could also make counterfeit products easier to package, post and pass off as legitimate.
The arrival of the first oral GLP-1 medicine approved for weight management in the UK is a significant development. Tablets are discreet, portable and reassuringly ordinary. Unfortunately, “reassuringly ordinary” is also a useful disguise.
An injectable pen looks like a specialist medical product. A tablet can arrive in a bottle, blister pack or padded envelope and appear little different from any other prescription dispatched through the post.
That distinction may be particularly useful to illegal sellers targeting people searching social media and unregulated websites for faster or cheaper access to weight-loss medication.
A New Medicine Creates a Familiar Opportunity
Counterfeit medicine is not a new problem. The format, however, may make the deception easier to present convincingly.
Illegal sellers do not necessarily require sophisticated delivery devices or unusually shaped packaging. A plausible box, a tidy blister strip and a professional-looking website may be enough to create an air of legitimacy.
The trouble is that packaging is theatre. It can look polished while concealing a product containing the wrong dose, no active ingredient or an entirely different substance.
According to the supplied figures, the MHRA seized almost £45 million worth of illegal medicines during 2025 and has uncovered organised criminal networks involved in manufacturing unlawful weight-loss products.
An approved tablet therefore enters a market where public demand is already high and criminal interest is hardly theoretical.
A Professional-Looking Box Proves Very Little
Qasim says the development offers a valuable alternative for patients who dislike injections, but that convenience should not be mistaken for safety.
“The arrival of an approved weight-loss tablet is an important development for patients, particularly those who are uncomfortable with injections. However, high demand and widespread online interest can also attract illegal sellers looking to exploit people who want quick or cheaper access.
A tablet may look less suspicious than an injection because consumers are accustomed to receiving pills through the post. But a professional-looking box, blister pack or website does not prove that the medicine is genuine.
Prescription weight-loss medication should only be supplied after an appropriate clinical assessment by a qualified healthcare professional. Any seller willing to bypass that process should immediately raise concern.”
That final point is the useful one. The most important evidence is not the shininess of the packet or the elegance of the checkout page. It is whether a legitimate healthcare process took place before the medicine was supplied.
The Seller Matters More Than the Packaging
Consumers should be wary of any seller offering prescription weight-loss medication without an appropriate clinical assessment.
A social-media account may have thousands of followers. A website may carry medical-looking photographs, testimonials and an impressive collection of badges. None of those features establishes that the medicine is genuine or that the person supplying it is qualified to do so.
The central warning signs are comparatively straightforward:
- The medicine is promoted through social media or an unregulated website.
- The seller offers prescription medication without a proper clinical assessment.
- Professional-looking packaging is presented as the main proof of authenticity.
- The seller promises unusually quick or cheaper access by bypassing normal healthcare safeguards.
A legitimate prescribing process may feel slower and less convenient than clicking a link beneath a social-media post. That inconvenience is not an administrative nuisance. It is part of the protection.
Why Counterfeit Tablets Carry Serious Risks
A fake weight-loss tablet is not merely a poor-value imitation. Its contents may bear little relationship to the label.
It could contain too much or too little of an active ingredient. It could contain none at all. It could also contain an entirely different substance, introducing risks that neither the buyer nor a healthcare professional can reasonably anticipate.
That uncertainty is particularly troubling when the product is being taken as medicine. A counterfeit watch may lose time. A counterfeit tablet can lose the plot altogether.
The growing recognition of GLP-1 medicines has created intense public interest, but familiarity with a treatment name does not make every product bearing that name legitimate.
Convenience Should Not Replace Clinical Care
The approval of an oral semaglutide treatment may remove one practical barrier for people who are uneasy about injections. It does not remove the need for qualified assessment, appropriate prescribing or regulated supply.
That distinction deserves to be stated plainly because illegal sellers tend to sell convenience first and medicine second.
A tablet may look harmless. A blister pack may look authentic. A website may look expensive. None of those things can diagnose a patient, assess whether treatment is appropriate or confirm what is actually inside the packet.
The safest warning sign is therefore also the simplest: when a seller is willing to bypass proper clinical care, the buyer should be willing to bypass the seller.
